{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:13:07Z","timestamp":1793052787867,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.antiviral.2013.11.013","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T19:35:53Z","timestamp":1386185753000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1"],"prefix":"10.1016","volume":"102","author":[{"given":"Wei","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.11.013_b0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1399-3011.1994.tb00559.x","article-title":"Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2","volume":"43","author":"Aboudy","year":"1994","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.antiviral.2013.11.013_b0010","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/AAC.01424-07","article-title":"Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides","volume":"52","author":"Akkarawongsa","year":"2008","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.antiviral.2013.11.013_b0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijantimicag.2003.07.022","article-title":"Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus","volume":"23","author":"Albiol Matanic","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2013.11.013_b0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jmv.20171","article-title":"Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface","volume":"74","author":"Andersen","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jmv.2134","article-title":"In vitro antiviral activity of dermaseptins against herpes simplex virus type 1","volume":"66","author":"Belaid","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0030","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1073\/pnas.0801388105","article-title":"Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus","volume":"105","author":"Bobardt","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.11.013_b0035","doi-asserted-by":"crossref","first-page":"e34947","DOI":"10.1371\/journal.pone.0034947","article-title":"Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.11.013_b0040","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.0712380105","article-title":"A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro","volume":"105","author":"Cheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.11.013_b0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0402-386","article-title":"Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease","volume":"8","author":"Crute","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.11.013_b0050","doi-asserted-by":"crossref","first-page":"e18917","DOI":"10.1371\/journal.pone.0018917","article-title":"HSV neutralization by the microbicidal candidate C5A","volume":"6","author":"Lot de Witte","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.11.013_b0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1386-6532(00)00169-4","article-title":"Herpes simplex virus antiviral drug resistance\u2013current trends and future prospects","volume":"21","author":"Field","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.31.3.361","article-title":"Acyclovir prophylaxis for herpes simplex virus infection","volume":"31","author":"Gold","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.11.013_b0065","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1128\/JVI.00377-12","article-title":"Aptamer that binds to the gD protein of herpes simplex virus 1 and efficiently inhibits viral entry","volume":"86","author":"Gopinath","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0070","first-page":"11","article-title":"Novel targets for the development of anti-herpes compounds","volume":"7","author":"Greco","year":"2007","journal-title":"Infect. Disord.: Drug Targets"},{"key":"10.1016\/j.antiviral.2013.11.013_b0075","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1128\/JVI.70.5.3137-3141.1996","article-title":"Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency","volume":"70","author":"Hill","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0080","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.biomaterials.2013.01.075","article-title":"Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus","volume":"34","author":"Hong","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.antiviral.2013.11.013_b0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bjp.2008.242","article-title":"Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures","volume":"155","author":"Hsiang","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2003.09.001","article-title":"Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate","volume":"61","author":"Jenssen","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.11.013_b0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2013.11.013_b0100","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.11.013_b0105","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses","volume":"32","author":"Li","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.antiviral.2013.11.013_b0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2010.02.316","article-title":"A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry","volume":"86","author":"Liu","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.11.013_b0115","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/pmic.200900763","article-title":"Molecular diversity of toxic components from the scorpion Heterometrus petersii venom revealed by proteomic and transcriptome analysis","volume":"10","author":"Ma","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.antiviral.2013.11.013_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0030-1250093","article-title":"Manzamine A as a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells","volume":"77","author":"Palem","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.antiviral.2013.11.013_b0125","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/AAC.47.2.494-500.2003","article-title":"NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2","volume":"47","author":"Sinha","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.11.013_b0130","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JVI.02250-06","article-title":"Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells","volume":"81","author":"Teuton","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.peptides.2010.10.008","article-title":"A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV","volume":"32","author":"Yan","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.antiviral.2013.11.013_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s100960050457","article-title":"Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides","volume":"19","author":"Yasin","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.11.013_b0145","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/JVI.78.10.5147-5156.2004","article-title":"Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry","volume":"78","author":"Yasin","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.013_b0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.antiviral.2011.10.009","article-title":"Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis","volume":"92","author":"Yoon","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.11.013_b0155","doi-asserted-by":"crossref","first-page":"30181","DOI":"10.1074\/jbc.M112.370312","article-title":"Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4alpha in vitro and in vivo","volume":"287","author":"Zhao","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T10:18:31Z","timestamp":1597141111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213003550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":31,"alternative-id":["S0166354213003550"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}